Loading...
OTCM
SHMN
Market cap1mUSD
Dec 05, Last price  
0.00USD
1D
10.00%
1Q
-38.89%
Jan 2017
1,000.00%
IPO
-99.99%
Name

SOHM Inc

Chart & Performance

D1W1MN
OTCM:SHMN chart
P/E
P/S
1.83
EPS
Div Yield, %
Shrs. gr., 5y
5.05%
Rev. gr., 5y
42.26%
Revenues
949k
+135.70%
278,142124,261173,955422,990162,898235,079324,905347,087402,645949,032
Net income
-608k
L+104.75%
-637,149-21,817-64,14152,14743,13133,09388,28192,579-296,898-607,893
CFO
-429k
L+1,043.16%
-244,431-563,010-63,59426,14232,9938,792111,199-37,548-429,235

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. The company also exports its products. SOHM, Inc. was founded in 2005 and is based in Corona, California.
IPO date
Oct 11, 2006
Employees
145
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT